- Prehypertension, Cause and Results
- Metabolic Syndrome and Borderline Metabolic Conditions
- Prehypertension- Mechanism, Diagnosis and Management
- Cumulative Effects of Multiple Borderline Cardiometabolic Risk Factors
- Prehypertension and Metabolic Syndrome in Different Populations – Epidemiology
- Prehypertension – Progression of Risk and Diagnosis of Disease
- Prevention and Regression of End Organ Damage in Prehypertension
- Natural History of Prehypertension, Hypertension and End Organ Damage
- The Heart, the Brain and the Kidney in Prehypertension and Cardiometabolic Syndrome
- Diabetes and End Organ Damage
- Prediabetes – Mechanism, Diagnosis, and Management
- Humoral Factors in Prehypertension and Cardiometabolic Syndrome
- Benefits of Achieving Optimal Risk Factors Level – When, How and with What?
- Total Cardiovascular Risk Evaluation and Management
- Complications of Prehypertension, Hypertension and Cardiometabolic Syndrome: the Heart, the Brain, the Kidney and the Extremities
- Arterial Properties, Evaluation and Treatment in Borderline Conditions
- Biomarkers of Borderline Conditions and Preclinical Disease
- Borderline Cardiovascular Risk Factors – Morbidity and Mortality
- Approach to the Elderly with Borderline Metabolic Conditions
- Children and Adolescents and Cardiovascular Risk Factors- Diagnosis, Estimation of Risk and Treatment
- Assessment of Global Cardiovascular Risk Factors in Borderline Conditions
- Arterial Properties, Central Blood Pressure and Augmentation Index in the Continuum of Prehypertension and Hypertension
- Prehypertension, Prediabetes and Dyslipidemia – Estimation of Risk and Therapeutic Approach
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.